The venture capital model, which relies on a few massive successes to offset numerous failures, is facing scrutiny within the health tech sector. Despite a recovery in funding, a significant portion of capital is concentrated in a small number of large deals, creating a divide between category winners and struggling companies. Exits are also uneven, with a preference for acquisitions over IPOs, leaving many late-stage companies in a difficult AI
RANK_REASON Article discusses the challenges and potential flaws in the standard venture capital model as applied to the health tech industry, rather than announcing a new product, funding round, or research.
- Airbnb
- Allumia Ventures
- Dan Galles
- Databricks
- Forbes
- Hinge Health
- Jessica Loché-Eggert
- Nelson Advisors
- Nvidia
- Omada Health
- Providence Ventures
- Rock Health
- Snowflake
- Stripe
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
